Laurion Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Laurion Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30,000	Closed	-$373K	–	1729
2016 Q4	$373K	Buy	+30,000	New	+$361K	﹤0.01%	893
2015 Q2	–	Sell	-15,500	Closed	-$128K	–	750
2015 Q1	$128K	Buy	+15,500	New	+$115K	﹤0.01%	315

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Laurion Capital Management's ARIA Position: Q1 2017 in Review

Laurion Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 30,000 shares — an estimated $373K sold.

Laurion Capital Management first reported a position in ARIA in Q1 2015 and held it in 2 quarters. The position peaked at $373K in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Laurion Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Laurion Capital Management sold 30,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $373K.
Laurion Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q1 2015 and held it in 2 quarters.
Laurion Capital Management's Ariad Pharmaceuticals Inc position peaked at $373K in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Laurion Capital Management's 13F filing for Q1 2017, filed 12 May 2017.